glp-1 receptor agonist nephrolithiasis Certain diabetes drugs linked to lower risk of kidney stones and gout Trends in the Development of
Description
Lets dive in
PVT, paraventricular nucleus of the thalamus
[DOI] [PubMed] [Google Scholar] 449.Holtmann M.H., Roettger B.F., Pinon D.I., Miller L.J
Sattar, N., Deanfield, J
Several GLP-1 receptor agonists have also demonstrated cardiovascular benefits in patients at high risk, although this is not a universal finding, as described later (2430)
Figure 1 Statements Author contributions RC: Writing review & editing, Writing original draft
